Inflammatory bowel disease-related economic costs due to presenteeism and absenteeism

Abstract

<b>Background:</b> Inflammatory bowel disease (IBD), consisting of Crohn's disease and ulcerative colitis, can be a lifelong burden generating high costs to an economic system. Data regarding the cost of workplace presenteeism and absenteeism in workers with IBD are limited. Our objective was to assess these costs in employed adults.<div><b>Methods:</b> A structured questionnaire, hospital records and national registers were combined to assess the economic costs involved with workplace presenteeism and absenteeism in employed patients. Our final sample comprised 320 IBD patients. The costs were calculated as productivity-loss costs by using a Human Capital Approach.</div><div><b>Results:</b> Due to IBD, the mean annual economic costs of workplace presenteeism were euro643.90/patient, and mean annual absenteeism costs were euro740.90/patient. Women had higher costs (euro955/patient/year) from absenteeism compared to men (euro531/patient/year) especially when working blue-collar jobs. These findings were also evident in presenteeism. CD and UC patients had similar total costs due to presenteeism and absenteeism. The use of biologics did not have a major impact on these costs.</div><div><b>Conclusion:</b> IBD patients had moderate economic costs from workplace presenteeism and absenteeism. Interestingly, women, working blue-collar jobs, had higher costs than men.</div>